*Sick of Big Pharma’s pricing, health insurers pledge $55M for cheap generics.*

Creating a drug company with other motives aside from profit is a good thing to do. Its competition could hold back other companies from gouging. However, there is a danger that the other companies could get out of that business or merge. That could lead to even less competition.

I hope the founders have taken very firm measures to prevent this company from being co-opted later and turned into a monopolistic super-gouger.